Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biotechnology Business
Celera Reports First Quarter Fiscal 2008 Results
November 9th, 2007
Celera Group (NYSE: CRA), an Applera Corporation business, reported revenues of $16.1 million for the first quarter of fiscal 2008, compared to $10.2 million in the prior year quarter. The first quarter fiscal 2008 results included $5.0 million of net revenues related to the achievement of a drug development license milestone by a third party and the resale of a small molecule drug development program as described under Financial Highlights below. For the first quarter of fiscal 2008, Celera reported net income of $0.7 million, or $0.01 per share, compared to a net loss of $7.1 million, or $0.09 per share, for the prior year quarter. The first quarter fiscal 2007 results included a pre-tax...
Source: Biotech Law Weekly (2007-11-09)
|
